Context Therapeutics Inc. (CNTX) Q4 2024 Annual Earnings
CNTX·Reported March 20, 2025·Before market open
Diluted EPS came in at $-0.04, beat the $-0.05 consensus by $0.01.
Diluted EPS
$-0.04beat by $0.01
Consensus: $-0.05
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Context Therapeutics Inc.'s Q4 2024 earnings report.
Context Therapeutics Inc. (CNTX) reported Q4 2024 earnings on March 20, 2025 before market open.
Context Therapeutics Inc. reported diluted EPS of $-0.04 for Q4 2024.
EPS beat the consensus estimate of $-0.05 by $0.01.
You can read the 10-K periodic report (0001842952-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.